Molecular Identification of Leishmania Species in an Outbreak of Re-Emerged Cutaneous Leishmaniasis in Southwestern Iran During 2015 - 2016

AUTHORS

Mehri Kargar 1 , Homa Hajjaran 1 , Javad Moazen 2 , Mohammad Reza Shirzadi 3 , Elham Kazemirad 1 , Hamid Kalantari 4 , Aref Teimouri 5 , Mehdi Mohebali 1 , 6 , *

1 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Infectious Diseases, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran

3 Zoonoses Control Unit, Center of Communicable Diseases, Ministry of Health, Treatment and Medical Education, Tehran, Iran

4 Dezful Health Center, Dezful, Iran

5 Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

6 Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, Iran

How to Cite: Kargar M, Hajjaran H , Moazen J, Shirzadi M R , Kazemirad E, et al. Molecular Identification of Leishmania Species in an Outbreak of Re-Emerged Cutaneous Leishmaniasis in Southwestern Iran During 2015 - 2016. Arch Clin Infect Dis. 2021;16(3):e82209. doi: 10.5812/archcid.82209.

ARTICLE INFORMATION

Archives of Clinical Infectious Diseases: 16 (3); e82209
Published Online: July 10, 2021
Article Type: Research Article
Received: July 16, 2018
Revised: May 21, 2021
Accepted: June 27, 2021
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Background: Dezful and its suburbs, as the second city in Khuzestan Province, southwest of Iran, has been an endemic area of cutaneous leishmaniasis (CL) with a low incidence rate since the last decades. However, the disease incidence has rapidly increased, and now is considered as a re-emerging parasitic disease in the area.

Objectives: The aim of this study was to identify the most prevalent CL species in Dezful Region.

Methods: A total of 196 microscopically confirmed slides from CL patients referred to Dezful Health Center were randomly collected in the period of 2015 - 2016. After DNA extraction from microscopically positive slides, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was carried out on 61 eligible specimens using ribosomal internal transcribed spacer 1 (ITS1) gene. The HaeIII restriction enzyme was used for the identification of species.

Results: Samples were randomly collected from 196 acute CL cases, including 110 (56.2%) males and 86 (43.8%) females. Most infections were seen in the age range of 2 - 7 years (65/196, 33.1%). Totally, 60.1% of the cases had only one lesion, and half of the lesions appeared on hands. Furthermore, 162 (82.7%) cases were referred to Dezful Health Center in the cold seasons (autumn and winter). Results of PCR-RFLP on 61 eligible isolates showed that 60 (98.4%) isolates were Leishmania major, and only 1 (1.6%) isolate was Leishmania tropica.

Conclusions: Our findings indicated that L. major is the main agent of re-emerged CL in Dezful and its suburbs, and the disease is a zoonosis.

1. Background

Leishmaniasis includes a group of parasitic diseases caused by species of obligating intra-macrophage protozoan Leishmania parasites (1). These parasites are transmitted to humans and animals by the bite of phlebotomine sand flies (1). Of 20 species of Leishmania, 18 species are zoonotic, creating a wide range of clinical symptoms such as cutaneous, diffuse cutaneous, mucocutaneous (espundia), and visceral (kala-azar) symptoms, as well as post kala-azar dermal leishmaniasis (PKDL) and recidivans (2). More than 90% of cutaneous leishmaniasis (CL) cases occur in America, Mediterranean basin, Middle East, and Central Asia regions. According to the World Health Organization (WHO), more than two-thirds of new CL cases occurred in Afghanistan, Algeria, Brazil, Colombia, Iran, and the Syrian Arab Republic (3). Approximately 0.7 to 1.2 million new cases are reported each year, with 20,000 to 40,000 leishmaniasis deaths annually (4). Many Leishmania infections are either asymptomatic or misdiagnosed (5, 6). In Iran, two species of Leishmania tropica and Leishmania major cause anthroponotic cutaneous leishmaniasis (ACL) and zoonotic CL (ZCL), respectively. Furthermore, visceral leishmaniasis (VL) is caused by L. donovani complex (7). Most ACL cases are reported from northeast (Khorasan-Razavi) and Southeast (Kerman) regions of Iran, while ZCL is distributed in northeast (Khorasan-Shomali), Central (Isfahan), and West (Ilam), as well as Southern provinces (Khouzestan and Bushehr). In Iran, more than 90% of the visceral cases are reported from the northwest and southern provinces, including Fars and Bushehr (7).

In recent decades, new leishmaniasis foci were expanded or emerged in Iran, indicating epidemiological changes in leishmaniasis distribution. Remarkably, these new foci have now become endemic for leishmaniasis, especially in tegumentary form (8-10). Some well-known reasons for this phenomenon include changes in environmental conditions, such as climate change, and human activities such as travel to endemic foci and migration (11). In Iran, nearly 18,000 - 20,000 new cases of CL are reported annually. Because of spontaneous healing of CL ulcers or delayed refer to health centers, the real number of the disease is estimated 4 - 5 times greater than the formal reports (3).

Prevention, control, and treatment of leishmaniasis depend on several factors, including the type of the disease, parasite species, and geographic location. In CL, the disease is diagnosed based on the clinical symptoms and parasitological tests (12). Leishmania spp. are directly identified through morphology studies in microscope slides of the clinical samples. Since several Leishmania spp. can be found in one study, and due to impossible differentiation of the species based on their morphology, direct microscopy lacks the necessary sensitivity and specificity (13). Molecular methods such as polymerase chain reaction (PCR) include good sensitivity and specificity. However, choosing target genes is important based on the study aims (13). Various types of PCR, including polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and nested-PCR, have been used for the diagnosis of Leishmania spp., as well as their species identification in the last decades (14).

Re-emerging infectious diseases include a group of diseases that have previously existed but are rapidly increasing or changing their geographic ranges. During the last decade, Dezful and its suburbs, as the second city of Khuzestan province in southwestern Iran, was an endemic area of CL with a low incidence rate. However, the disease rapidly increased from 372 new cases in 2013 to 1,917 cases in 2015. Thus, CL is now described as a re-emerging parasitic disease in this area. Khuzestan Province is one of the old endemic foci of CL in Iran (15). A long border with Iraq, where no controls exist over leishmaniasis due to war and political problems, has resulted in an increased number of CL cases. A close distance to endemic CL foci such as Bushehr, Ilam, and Isfahan provinces affects new foci in Khuzestan province (16-19). Several studies have been carried out in Khuzestan to molecularly characterize Leishmania spp. in human cutaneous lesions (15).

2. Objectives

Therefore, the aim of the current study was to genotype the most prevalent CL strains in Dezful region using PCR-RFLP and sequencing of the ITS1 gene.

3. Methods

3.1. Study Area

The present study was carried out in Dezful, Southwestern Iran, locating along the Dez River in Central Zagros. Dezful is hot and humid, with a history dating back to Sassanian Empire. Dezful is restricted to Andimeshk and Aligoodarz Counties (Lorestan Province) from the north, Lali District of Masjed Soleiman City and Gotvand District of Shushtar City from the east, and Shush City from the south and west (20).

3.2. Sampling, DNA Extraction, PCR, and PCR-RFLP

Totally, 196 Giemsa-stained slides from the patients referred to Dezful Health Center during 2015 - 2016 were collected. The samples were sent to the Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences, Tehran, Iran, for further studies. The preliminary information of the patients, including age, sex, living area, as well as the number, site, and duration of lesions, were recorded in questionnaires. Presence of amastigotes was checked by preparing smears from exudates of lesions, then fixing in methanol and staining by Giemsa, and studying under light microscope. Patients were chosen according to WHO protocols of 4+ (1 - 10 parasites/fields), 3+ (1 - 10 parasites/10 fields), 2+ (1 - 10 parasites/100 fields), and 1+ (1 - 10 parasites/1000 fields) (5). DNA was extracted from 61 samples using DNA extraction kit according to manufacturer’s instructions (Bioneer, Korea). DNA extracts were stored at -20°C until use. PCR on ITS1 gene was carried out using primer set of LITSR (forward: 5’-CTGGATCATTTTCCGATG-3’) and L5.8S (reverse: 5’-TGATACCACTTATCGCACTT-3’) as previously described (21). PCR amplifications were carried out using a thermal cycler in a 25-µL total volume, containing 2.0  µL 10× PCR buffer, 1.2 µL of dNTP mixture (25 mM), 1.6  µL of MgCL2 (25 mM), 1 U of Taq polymerase, 2 µL of each forward and reverse primers (10 pmol), and 1 µL of DNA template (about 20 ng). Amplification results were compared to the standard control from Iranian reference strains of L. tropica (MHOM/IR/02/Mash10/Accession No. EF653267) and L. major (MRHO/IR/11/GOL-2/accession no.: JN860745). The following condition was used in thermal cycler (Peqlab, Erlangen Germany): an initial denaturing cycle at 95°C for 5 min, followed by 35 cycles of 94°C for 30 s, 59°C for 30 s, and 72°C for 45 s. The final extension cycle was carried out at 72°C for 7 min. A fragment of approximately 300 - 350 bp was amplified in PCR (21, 22). The PCR products were visualized using electrophoresis on 1.2% safe-stained agarose gels and ultraviolet (UV) light. In RFLP, 10 µL of the PCR products (concentration 1 µg/µL) was mixed with 2 µL of the 10x enzyme buffer and 1 µL of the restriction HaeIII (10 units/µL) enzyme (Fermentas, Germany) and incubated at 37°C for 10 min. Cutting site of the enzyme included GG CC, producing various patterns based on the Leishmania species. Separation of the digested products was carried out using electrophoresis on 3% agarose gels.

3.3. Sequencing and Phylogenetic Analysis

For genotyping and phylogenetic analysis, six samples were sequenced in Bioneer Co., Korea, using ABI 3730 Sequencer. Sequences were checked manually for ambiguities using BioEdit software V.7.1.3.0. DNA sequences were compared to sequences from GenBank Database using Basic Local Alignment Search tool (BLAST). Phylogenetic trees were constructed using the Neighbor-Joining (NJ) method and Tamura 3-parameter for DNA sequences using MEGA 5 software V.5.0) (23). Bootstrap values were set as 1,000 replicates.

3.4. Ethics

The study protocol was approved by the Ethics Committees of Tehran University of Medical Sciences, Iran (approval no.: 34213), and oral consent was obtained from all participants. No information of the patients was revealed in the study.

4. Results

In this study, a total of 196 CL infected patients verified by microscopy (1000×) were selected (Table 1).

Table 1. Distribution of Samples Collected from Acute CL Patients in Dezful and its Suburbs During 2015 - 2016
CityNumber of Patients (%)
Dezful55 (28)
Shush121 (62)
Gotvand20 (10)
Total 196 (100)

Out of 196 patients, 110 (56.2%) and 86 (43.8%) cases were male and female, respectively (Table 2). The average age of the patients was 32 years old, with a mean number of ulcers of two and a lesion duration of 97 days. In 50.5% of the cases, hands were subjects to lesions and 72.15% of the cases included wet lesions. More than half of the cases (60.1%) had one lesions with a mean duration of 32 days.

Table 2. Main Characteristics and Types of Clinical Lesions in 196 Microscopically Confirmed CL Patients in Dezful and Its Suburbs During 2015 - 2016
CharacteristicNo. (%)
Age group, y
≤ 118 (9.2)
2 - 765 (33.1)
8 - 1541 (20.9)
16 - 2521 (10.7)
26 - 3520 (10.2)
36 - 4514 (7.2)
46 - 5510 (5.1)
56 - 655 (2.6)
≥ 662 (1)
Gender
Male110 (56.2)
Female86 (43.8)
Number of lesions
Single form118 (60.1)
Double form34 (17.4)
Multiple form44 (22.5)
Location of lesion
Hand102 (50.5)
Leg28 (13.8)
Face and head62 (30.7)
Other parts the body10 (5)
Lesion appearance
Dry17 (27.9)
Wet44 (72.1)
Parasitemia rate
> 4187 (95.5)
≤ 49 (4.5)

Categorizing samples based on the season showed that 13 (6.6) cases occurred in spring, 21 (10.7) in summer, 64 (32.7) in autumn, and 98 (50) in winter (Figure 1). In direct smear study, parasitemia rated from 1+ to 4+ and 9 (4.5) cases were 4+.

Figure 1. Monthly distribution of CL cases referred to Health Centers of Dezful and its suburbs during 2015 - 2016

In molecular study, 61 clinical samples were positive for Leishmania spp. using PCR. In RFLP, 60 (98.37) sample patterns were identical to that of L. major and 1 (1.63) to that of L. tropica, compared to the reference strain (Table 3 and Figure 2). The cities with the highest rates of L. major infection were Shush (72.2), Dezful (19.6), and Gotvand (6.5), respectively. The only case of L. tropica was isolated from Dezful.

Figure 2. RFL) Patterns from Leishmania stock and patient samples using HaeIII Enzyme. Lanes 1, 2, 3, L. major; Lane 4, L. tropica; Lane 5, L. major as references strain; Lane 6, L. tropica as references strain; M, 100-bp size marker.
Table 3. Distribution of Leishmania spp. Using PCR-RFLP Method Based on the Living Places of CL Cases in Dezful and its Suburbs During 2015 - 2016
Leishmania spp.Dezful, No. (%)Shush, No. (%)Gotvand, No. (%)Total, No. (%)
L. major12 (19.6)44 (72.2)4 (6.5)60 (98.83)
L. tropica1 (1.17)001 (1.17)
Total13 (20.77)44 (72.2)4 (6.5)61 (100)

4.1. Phylogenetic Tree

The phylogenetic tree from the sequences of ITS1 fragments clearly showed divergence between L. major and L. tropica isolates. Leishmania isolates were grouped into two main clades representing L. major and L. tropica. The single successfully sequenced L. tropica isolate from Dezful in the present study was placed in the cluster of other L. tropica sequences. Furthermore, homogeneity was observed among the L. major isolates from different geographical sites of our study. No clear grouping was demonstrated for the 20 isolates according to their geographical origins (Figure 3).

Figure 3. The neighbor-joining tree from ITS1 region of Leishmania isolates using tamura 3 parameter

Bootstrap resampling values are shown at each branch. Isolates from the current study are marked by circles (L. major) and squares (L. tropica). L. infantum and T. cruzi DNA sequences were used as the out-group.

5. Discussion

Khuzestan is one of the most significant endemic areas of CL in southwestern Iran. Studies in this area have shown increased CL cases and genesis of new foci of the disease. In recent years, novel leishmanial foci, such as Dezful, Shush, and Gotvand, have been reported, indicating the potential spread of the disease in this area (24). In last decades, Dezful and its suburbs, as the second big city in Khozestan Province, was an endemic area of CL with low prevalence rates, but the disease rapidly increased from 372 new cases in 1994 to 1917 cases in 2015. Although studies have been carried out in different cities of Khuzestan, no information is available on the multiple circulating Leishmania spp. in the highlighted foci. Therefore, the current cross-sectional study was carried out during 2015 - 2016 on 196 Giemsa-stained slides from patients referred to health centers in Dezful, Gotvand, and Shush. Use of Giesma-stained slides is an appropriate method for field practices (22, 25). The method is advantageous in figuring out controversial cases or epidemiological studies that need integration.

Based on the current results, the number of infected males was greater than that of infected females. A similar study by Maraghi et al. (15) in Shush showed that the prevalence rate in males was higher than that in females. The greater prevalence in males might be a result of further outdoor working, less outfit covering, further traveling in desert areas, and greater possibility of contacting with sand flies (15). In 2014, Nilforoushzadeh et al. (26) showed that prevalence of the infection in males was two times greater than that in females, possibly due to the large number of males who worked as seasonal migrant labors or expatriates. Findings of the current study showed that the highest infected age group included 2 - 7 years old with a rate of 33.1%. This age group consists of children who usually play outdoor, and hence further expose to the causative agent. Maraghi et al. (15) in Shush showed that 42% of the CL infections occurred in children under 10 years old. Nejati et al. (25) reported a 41.6% rate for the infection, mostly in 15- to 24-year-old young people in Andimeshk. Nilforoushzadeh et al. (26) showed that the prevalence of leishmaniasis increased in individuals younger than 15 years old in endemic areas (26). The difference in results might be due to the restriction of the disease to native areas. Since under 10-year-old children are more likely to be infected with the pathogen in areas such as Shush, and hence acquire life-time immunity, infection in elder people is less possible (15).

In the current study, CL lesions were most frequently located on hands of the patients (50.5%), which was similar to that reported previously (15, 26). Studies from zoonotic CL areas in Iran and Saudi Arabia showed the maximum occurrence of lesions in uncovered body parts (15, 26). Findings from the present study showed that the seasonal pattern of the disease was in early winter (50%) between December to January (24.8%). Results from the previous studies showed that the highest and the lowest rates of seasonal leishmaniasis in Ahvaz, capital city of Khuzestan Province, were seen in autumn (49.2%) and spring (9%) respectively (27). Furthermore, results showed that most of the patients had only one lesion (60.3%) mostly on hands (50%). Results from other studies demonstrated that the number of lesions in leishmaniasis varied between 1 - 3 lesions per patient (28.3%) (28). Results from the molecular methods (ITS1-PCR RFLP) indicated that 98.4% of the CL cases in Dezful, Shush, and Gotvand were caused by L. major and 1.6% by L. tropica. Studies by Spotin et al. (29) in four areas of Khuzestan (North, South, West, and East) showed that 100% of CL cases were caused by L. major (30). Research by Maraghi et al. (30) demonstrated L. major as the predominant type of Leishmania spp. in Khuzestan. Maraghi et al. (15) reported that 90% of Leishmania spp. were L. major, which was similar to the reports from the present study. Other evidence including lesion type, number of ulcers, wet ulcer, seasonal distribution of the disease, and parasitism helped to verify these reports as most of the lesions were wet and existed in the lower parts of the body. These signs usually belong to rural form of leishmaniasis caused by L. major.

In general, prevalence of CL in Dezful, Shush, and Gotvand is remarkable. Despite low levels of genetic diversity in Iranian Leishmania isolates, sequence analysis was able to show at least one haplotype of L. major and L. tropica. No correlation was seen between the clinical symptoms in CL patients and genotype of the studied L. major isolates. In this study, the molecular methodology did not show any correlation between this haplotype and other Iranian L. major haplotypes from endemic areas. Indeed, results did not demonstrate any correlation between the haplotypes and the geographical areas, similar to the reports from other studies (31, 32).

5.1. Conclusions

Findings from this study show that L. major is the main agent of the re-emerged CL in Dezful and its suburbs and the disease is a zoonosis. Physicians and public health managers must be alerted, and hence further inter-sectorial collaborations are needed to limit primary reservoir hosts (gerbils particularly Tatera indica) in the studied areas. Moreover, further investigations and epidemiological studies on the disease are necessary.

Footnotes

References

  • 1.

    Akhoundi M, Kuhls K, Cannet A, Votypka J, Marty P, Delaunay P, et al. A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies. PLoS Negl Trop Dis. 2016;10(3). e0004349. doi: 10.1371/journal.pntd.0004349. [PubMed: 26937644]. [PubMed Central: PMC4777430].

  • 2.

    Savoia D. Recent updates and perspectives on leishmaniasis. J Infect Dev Ctries. 2015;9(6):588-96. doi: 10.3855/jidc.6833. [PubMed: 26142667].

  • 3.

    Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the middle East: incidence and epidemiology. PLoS Negl Trop Dis. 2014;8(10). e3208. doi: 10.1371/journal.pntd.0003208. [PubMed: 25275483]. [PubMed Central: PMC4183486].

  • 4.

    Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5). e35671. doi: 10.1371/journal.pone.0035671. [PubMed: 22693548]. [PubMed Central: PMC3365071].

  • 5.

    Mohebali M, Kazemirad E, Hajjaran H, Kazemirad E, Oshaghi MA, Raoofian R, et al. Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport. Arch Dermatol Res. 2019;311(1):9-17. doi: 10.1007/s00403-018-1872-2. [PubMed: 30390113].

  • 6.

    Gonzalez U, Pinart M, Sinclair D, Firooz A, Enk C, Velez ID, et al. Vector and reservoir control for preventing leishmaniasis. Cochrane Database Syst Rev. 2015;(8). CD008736. doi: 10.1002/14651858.CD008736.pub2. [PubMed: 26246011]. [PubMed Central: PMC4561525].

  • 7.

    Mohebali M. Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features. Iran J Parasitol. 2013;8(3):348-58. [PubMed: 24454426]. [PubMed Central: PMC3887234].

  • 8.

    Montalvo AM, Fraga J, Monzote L, Montano I, De Doncker S, Dujardin JC, et al. Heat-shock protein 70 PCR-RFLP: a universal simple tool for Leishmania species discrimination in the New and Old World. Parasitology. 2010;137(8):1159-68. doi: 10.1017/S0031182010000089. [PubMed: 20441679].

  • 9.

    Hajjaran H, Mohebali M, Alimoradi S, Abaei MR, Edrissian GH. Isolation and characterization of pathogenic Leishmania turanica from Nesokia indica (Rodentia, Muridae) by PCR-RFLP and ITS1 sequencing in Iran. Trans R Soc Trop Med Hyg. 2009;103(11):1177-9. doi: 10.1016/j.trstmh.2008.08.016. [PubMed: 18829057].

  • 10.

    Mohebali M, Javadian E, Yaghoobi-Ershadi MR, Akhavan AA, Hajjaran H, Abaei MR. Characterization of Leishmania infection in rodents from endemic areas of the Islamic Republic of Iran. East Mediterr Health J. 2004;10(4-5):591-9. [PubMed: 16335651].

  • 11.

    King RJ, Campbell-Lendrum DH, Davies CR. Predicting geographic variation in cutaneous leishmaniasis, Colombia. Emerg Infect Dis. 2004;10(4):598-607. doi: 10.3201/eid1004.030241. [PubMed: 15200848]. [PubMed Central: PMC3323104].

  • 12.

    Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581-96. doi: 10.1016/S1473-3099(07)70209-8. [PubMed: 17714672].

  • 13.

    Shahbazi F, Shahabi S, Kazemi B, Mohebali M, Abadi AR, Zare Z. Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods. Parasitol Res. 2008;103(5):1159-62. doi: 10.1007/s00436-008-1111-4. [PubMed: 18651180].

  • 14.

    Reithinger R, Dujardin JC. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol. 2007;45(1):21-5. doi: 10.1128/JCM.02029-06. [PubMed: 17093038]. [PubMed Central: PMC1828971].

  • 15.

    Maraghi S, Zadeh AS, Sarlak AA, Ghasemian M, Vazirianzadeh B. Identification of cutaneous leishmaniasis agents by nested Po-Lymerase chain reaction (Nested-PCR) in Shush City, Khuzestan Province, Iran. Iran J Parasitol. 2007;2(3):13-5.

  • 16.

    Feiz Haddad MH, Ghasemi E, Maraghi S, Tavala M. Identification of Leishmania Species Isolated from Human Cutaneous Leishmaniasis in Mehran, Western Iran Using Nested PCR. Iran J Parasitol. 2016;11(1):65-72. [PubMed: 27095970]. [PubMed Central: PMC4835471].

  • 17.

    Kassiri H, Kasiri A, Najafi H, Lotfi M, Kasiri E. Epidemiological features, clinical manifestation and laboratory findings of patients with cutaneous leishmaniasis in Genaveh County, Bushehr Province, Southern Iran. J Coast Life Med. 2014:1002-6.

  • 18.

    Kermanjani A, Akhlaghi L, Oormazdi H, Hadighi R. Isolation and identification of cutaneous leishmaniasis species by PCR-RFLP in Ilam province, the west of Iran. J Parasit Dis. 2017;41(1):175-9. doi: 10.1007/s12639-016-0772-7. [PubMed: 28316408]. [PubMed Central: PMC5339195].

  • 19.

    Arjmand R, Saberi S, Tolouei S, Chizari Z, Nobari RF, Fard SS, et al. Identification of Leishmania isolates from Varzaneh city, Isfahan province, Iran using nested polymerase chain reaction method. Adv Biomed Res. 2014;3:167. doi: 10.4103/2277-9175.139131. [PubMed: 25221770]. [PubMed Central: PMC4162079].

  • 20.

    Lotfi H, Nahavandian M, Ghasemnia N. Natural geographic features in Dezful and Susa in the development of sustainable tourism. Int J Appl Manag Sci. 2016;2(3):42-7.

  • 21.

    Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, Presber W, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis. 2003;47(1):349-58. doi: 10.1016/s0732-8893(03)00093-2. [PubMed: 12967749].

  • 22.

    Hajjaran H, Mohebali M, Mamishi S, Vasigheh F, Oshaghi MA, Naddaf SR, et al. Molecular identification and polymorphism determination of cutaneous and visceral leishmaniasis agents isolated from human and animal hosts in Iran. Biomed Res Int. 2013;2013:789326. doi: 10.1155/2013/789326. [PubMed: 24286085]. [PubMed Central: PMC3826333].

  • 23.

    Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evolut. 1987;4(4):406-25.

  • 24.

    Akhoundi M, Mohebali M, Asadi M, Mahmodi MR, Amraei K, Mirzaei A. Molecular characterization of Leishmania spp. in reservoir hosts in endemic foci of zoonotic cutaneous leishmaniasis in Iran. Folia Parasitol (Praha). 2013;60(3):218-24. doi: 10.14411/fp.2013.024. [PubMed: 23951928].

  • 25.

    Nejati J, Mojadam M, Hanafi-Bojd AA, Keyhani A, Habibi NF. An epidemiological study of cutaneous leishmaniasis in Andimeshk (2005-2010). Sci J Ilam Univ Med Sci. 2013;21(7):94-100.

  • 26.

    Nilforoushzadeh MA, Shirani Bidabadi L, Hosseini SM, Fadaei Nobari R, Jaffary F. Cutaneous Leishmaniasis in Isfahan Province, Iran, During 2001-2011. J Skin Stem Cell. 2014;1(2). doi: 10.17795/jssc23303.

  • 27.

    Naghash A. Cutaneous leishmaniasis of Ahwaz. Nabz J. 2015:26-2.

  • 28.

    Rafati N, Shapori-Moghadam A, Ghorbani R. Epidemiological survey of cutaneous leishmaniasis in Damghan (1999-2005). Sci J Semnan Univ Med Sci. 2004;2(1):247-53.

  • 29.

    Spotin A, Rouhani S, Parvizi P. The associations of Leishmania major and Leishmania tropica aspects by focusing their morphological and molecular features on clinical appearances in Khuzestan Province, Iran. Biomed Res Int. 2014;2014:913510. doi: 10.1155/2014/913510. [PubMed: 25317423]. [PubMed Central: PMC4181938].

  • 30.

    Maraghi S, Mardanshah O, Rafiei A, Samarbafzadeh A, Vazirianzadeh B. Identification of Cutaneous Leishmaniasis Agents in Four Geographical Regions of Khuzestan Province Using Nested PCR. Jundishapur J Microbiol. 2013. doi: 10.5812/jjm.4866.

  • 31.

    Teimouri A, Mohebali M, Kazemirad E, Hajjaran H. Molecular Identification of Agents of Human Cutaneous Leishmaniasis and Canine Visceral Leishmaniasis in Different Areas of Iran Using Internal Transcribed Spacer 1 PCR-RFLP. J Arthropod Borne Dis. 2018;12(2):162-71. [PubMed: 30123810]. [PubMed Central: PMC6091798].

  • 32.

    Hajjaran H, Mohebali M, Teimouri A, Oshaghi MA, Mirjalali H, Kazemi-Rad E, et al. Identification and phylogenetic relationship of Iranian strains of various Leishmania species isolated from cutaneous and visceral cases of leishmaniasis based on N-acetylglucosamine-1-phosphate transferase gene. Infect Genet Evol. 2014;26:203-12. doi: 10.1016/j.meegid.2014.05.026. [PubMed: 24911282].

  • Copyright © 2021, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: